Letter to the New York stem cell research program ethics board
By Jesse Reynolds and Susan Fogel
| 01. 21. 2009
Dear Members of the NYSTEM Ethics Board:
We are supporters of embryonic stem cell research who wish to express our deep concerns about your upcoming consideration of permitting payments to women to provide eggs for stem cell research. Multiple egg extraction poses risks to women's health without a clear and demonstrable scientific rationale, and allowing payments for eggs is contrary to the guidelines set by the National Academies of Science.
The extraction of eggs poses nontrivial health risks for the women. The drug most often used to shut down the ovaries, Lupron, can cause side effects, including severe joint pain, difficulty breathing, chest pain, depression, amnesia, hypertension, and asthma. The drugs used to hyperstimulate the ovaries can lead to Ovarian Hyperstimulation Syndrome, which in the most severe cases can lead to hospitalization and, rarely, death. The Institute of Medicine report, Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research, makes clear how little is known about the full risks of multiple egg extraction. In fact, the limited research has been done on infertile women, and therefore virtually...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
